Skip to main content
Top
Published in: Pituitary 5/2015

01-10-2015

A diagnostic pitfall in IgG4-related hypophysitis: infiltration of IgG4-positive cells in the pituitary of granulomatosis with polyangiitis

Authors: Hironori Bando, Genzo Iguchi, Hidenori Fukuoka, Masaaki Taniguchi, Seiji Kawano, Miki Saitoh, Kenichi Yoshida, Ryusaku Matsumoto, Kentaro Suda, Hitoshi Nishizawa, Michiko Takahashi, Akio Morinobu, Eiji Kohmura, Wataru Ogawa, Yutaka Takahashi

Published in: Pituitary | Issue 5/2015

Login to get access

Abstract

Introduction

Immunoglobulin (Ig) G4-related hypophysitis is an emerging clinical entity, which is characterized by an elevated serum IgG4 concentration and infiltration of IgG4-positive plasma cells in the pituitary. Although some criteria for its diagnosis have been proposed, they have not been fully established. In particular, differential diagnosis from secondary chronic inflammation including granulomatosis with polyangiitis (GPA) is difficult in some cases. We describe central diabetes insipidus with pituitary swelling exhibiting infiltration of IgG4-positive cells.

Patient

A 43-year-old woman in the remission stage of GPA presented with sudden-onset polyuria and polydipsia. Pituitary magnetic resonance imaging revealed swelling of the anterior and posterior pituitary and stalk, with heterogeneous gadolinium enhancement and disappearance of the high signal intensity of the posterior pituitary. Evaluation of biochemical markers for GPA suggested that the disease activity was well-controlled. Endocrinological examination revealed the presence of central diabetes insipidus and growth hormone deficiency. Pituitary biopsy specimen showed IgG4-positive cells, with a 43 % IgG4+/IgG+ ratio, which met the criteria for IgG4-related hypophysitis. However, substantial infiltration of polymorphonuclear neutrophils with giant cells was also noted, resulting in a final diagnosis of pituitary involvement of GPA.

Conclusion

These results suggest that pituitary involvement of GPA should be taken into account for the differential diagnosis of IgG4-related hypophysitis.
Literature
1.
go back to reference Shimatsu A, Oki Y, Fujisawa I, Sano T (2009) Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr J 56:1033–1041CrossRefPubMed Shimatsu A, Oki Y, Fujisawa I, Sano T (2009) Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr J 56:1033–1041CrossRefPubMed
2.
go back to reference Bando H, Iguchi G, Fukuoka H, Taniguchi M, Yamamoto M, Matsumoto R, Suda K, Nishizawa H, Takahashi M, Kohmura E, Takahashi Y (2014) The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and/or central diabetes insipidus and review of the literature. Eur J Endocrinol 170:161–172CrossRefPubMed Bando H, Iguchi G, Fukuoka H, Taniguchi M, Yamamoto M, Matsumoto R, Suda K, Nishizawa H, Takahashi M, Kohmura E, Takahashi Y (2014) The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and/or central diabetes insipidus and review of the literature. Eur J Endocrinol 170:161–172CrossRefPubMed
3.
go back to reference Leporati P, Landek-Salgado MA, Lupi I, Chiovato L, Caturegli P (2011) IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab 96:1971–1980PubMedCentralCrossRefPubMed Leporati P, Landek-Salgado MA, Lupi I, Chiovato L, Caturegli P (2011) IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab 96:1971–1980PubMedCentralCrossRefPubMed
4.
go back to reference Osawa S, Ogawa Y, Watanabe M, Tominaga T (2009) Hypophysitis presenting with atypical rapid deterioration: with special reference to immunoglobulin G4-related disease-case report. Neurol Med Chir (Tokyo) 49:622–625CrossRef Osawa S, Ogawa Y, Watanabe M, Tominaga T (2009) Hypophysitis presenting with atypical rapid deterioration: with special reference to immunoglobulin G4-related disease-case report. Neurol Med Chir (Tokyo) 49:622–625CrossRef
5.
go back to reference Hattori Y, Tahara S, Ishii Y, Kitamura T, Inomoto C, Osamura RY, Teramoto A, Morita A (2013) A case of IgG4-related hypophysitis without pituitary insufficiency. J Clin Endocrinol Metab 98:1808–1811CrossRefPubMed Hattori Y, Tahara S, Ishii Y, Kitamura T, Inomoto C, Osamura RY, Teramoto A, Morita A (2013) A case of IgG4-related hypophysitis without pituitary insufficiency. J Clin Endocrinol Metab 98:1808–1811CrossRefPubMed
6.
go back to reference Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1–11CrossRefPubMed Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1–11CrossRefPubMed
7.
go back to reference Yi ES, Colby TV (2001) Wegener’s granulomatosis. Semin Diagn Pathol 18:34–46PubMed Yi ES, Colby TV (2001) Wegener’s granulomatosis. Semin Diagn Pathol 18:34–46PubMed
8.
go back to reference Woywodt A, Haubitz M, Haller H, Matteson EL (2006) Wegener’s granulomatosis. Lancet 367:1362–1366CrossRefPubMed Woywodt A, Haubitz M, Haller H, Matteson EL (2006) Wegener’s granulomatosis. Lancet 367:1362–1366CrossRefPubMed
9.
go back to reference Yong TY, Li JY, Amato L, Mahadevan K, Phillips PJ, Coates PS, Coates PT (2008) Pituitary involvement in Wegener’s granulomatousis. Pituitary 11:77–84CrossRefPubMed Yong TY, Li JY, Amato L, Mahadevan K, Phillips PJ, Coates PS, Coates PT (2008) Pituitary involvement in Wegener’s granulomatousis. Pituitary 11:77–84CrossRefPubMed
10.
go back to reference Kallenberg CG, Mulder AH, Tervaert JW (1992) Antineutrophil cytoplasmic antibodies: a still growing class of autoantibodies in inflammatory disorders. Am J Med 93:675–682CrossRefPubMed Kallenberg CG, Mulder AH, Tervaert JW (1992) Antineutrophil cytoplasmic antibodies: a still growing class of autoantibodies in inflammatory disorders. Am J Med 93:675–682CrossRefPubMed
11.
12.
go back to reference Chang SY (2013) IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener’s): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases. Hum Pathol 44:2432–2437CrossRefPubMed Chang SY (2013) IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener’s): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases. Hum Pathol 44:2432–2437CrossRefPubMed
13.
go back to reference Ebbo M, Grados A, Bernit E, Vély F, Boucraut J, Harlé JR, Daniel L, Schleinitz N (2012) Pathologies associated with serum IgG4 elevation. Int J Rheumatol 2012:602809PubMedCentralCrossRefPubMed Ebbo M, Grados A, Bernit E, Vély F, Boucraut J, Harlé JR, Daniel L, Schleinitz N (2012) Pathologies associated with serum IgG4 elevation. Int J Rheumatol 2012:602809PubMedCentralCrossRefPubMed
14.
go back to reference Nishioka H, Shibuya M, Haraoka J (2010) Immunohistochemical study for IgG4-positive plasmacytes in pituitary inflammatory lesions. Endocr Pathol 21:236–241CrossRefPubMed Nishioka H, Shibuya M, Haraoka J (2010) Immunohistochemical study for IgG4-positive plasmacytes in pituitary inflammatory lesions. Endocr Pathol 21:236–241CrossRefPubMed
15.
go back to reference Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107CrossRefPubMed Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107CrossRefPubMed
16.
go back to reference Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, Mahr A, Segelmark M, Cohen-Tervaert JW, Scott D (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222–227PubMedCentralCrossRefPubMed Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, Mahr A, Segelmark M, Cohen-Tervaert JW, Scott D (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222–227PubMedCentralCrossRefPubMed
17.
go back to reference Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, Klöppel G, Heathcote JG, Khosroshahi A, Ferry JA, Aalberse RC, Bloch DB, Brugge WR, Bateman AC, Carruthers MN, Chari ST, Cheuk W, Cornell LD, Fernandez-Del Castillo C, Forcione DG, Hamilos DL, Kamisawa T, Kasashima S, Kawa S, Kawano M, Lauwers GY, Masaki Y, Nakanuma Y, Notohara K, Okazaki K, Ryu JK, Saeki T, Sahani DV, Smyrk TC, Stone JR, Takahira M, Webster GJ, Yamamoto M, Zamboni G, Umehara H, Stone JH (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181–1192 Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, Klöppel G, Heathcote JG, Khosroshahi A, Ferry JA, Aalberse RC, Bloch DB, Brugge WR, Bateman AC, Carruthers MN, Chari ST, Cheuk W, Cornell LD, Fernandez-Del Castillo C, Forcione DG, Hamilos DL, Kamisawa T, Kasashima S, Kawa S, Kawano M, Lauwers GY, Masaki Y, Nakanuma Y, Notohara K, Okazaki K, Ryu JK, Saeki T, Sahani DV, Smyrk TC, Stone JR, Takahira M, Webster GJ, Yamamoto M, Zamboni G, Umehara H, Stone JH (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181–1192
18.
go back to reference Rosete A, Cabral AR, Kraus A, Alarcón-Segovia D (1991) Diabetes insipidus secondary to Wegener’s granulomatosis: report and review of the literature. J Rheumatol 18:761–765PubMed Rosete A, Cabral AR, Kraus A, Alarcón-Segovia D (1991) Diabetes insipidus secondary to Wegener’s granulomatosis: report and review of the literature. J Rheumatol 18:761–765PubMed
19.
go back to reference Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488–498CrossRefPubMed Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488–498CrossRefPubMed
20.
go back to reference Ahlström CG, Liedhölm K, Truedsson E (1953) Respirato-renal type of polyarteritis nodosa. Acta Med Scand. 144:323–332CrossRefPubMed Ahlström CG, Liedhölm K, Truedsson E (1953) Respirato-renal type of polyarteritis nodosa. Acta Med Scand. 144:323–332CrossRefPubMed
21.
go back to reference Kapoor E, Cartin-Ceba R, Specks U, Leavitt J, Erickson B, Erickson D (2014) Pituitary dysfunction in granulomatosis with polyangiitis: the mayo clinic experience. J Clin Endocrinol Metab 99:3988–3994CrossRefPubMed Kapoor E, Cartin-Ceba R, Specks U, Leavitt J, Erickson B, Erickson D (2014) Pituitary dysfunction in granulomatosis with polyangiitis: the mayo clinic experience. J Clin Endocrinol Metab 99:3988–3994CrossRefPubMed
22.
go back to reference Goyal M, Kucharczyk W, Keystone E (2000) Granulomatous hypophysitis due to Wegener’s granulomatosis. AJNR Am J Neuroradiol 21:1466–1469PubMed Goyal M, Kucharczyk W, Keystone E (2000) Granulomatous hypophysitis due to Wegener’s granulomatosis. AJNR Am J Neuroradiol 21:1466–1469PubMed
23.
go back to reference Sampei S, Watanabe R, Ishii T, Harigae H (2014) Granulomatosis with polyangiitis preceded by central diabetes insipidus. Intern Med 53:1725–1726CrossRefPubMed Sampei S, Watanabe R, Ishii T, Harigae H (2014) Granulomatosis with polyangiitis preceded by central diabetes insipidus. Intern Med 53:1725–1726CrossRefPubMed
24.
go back to reference Al-Fakhouri A, Manadan A, Gan J, Sreih AG (2014) Central diabetes insipidus as the presenting symptom of granulomatosis with polyangiitis. J Clin Rheumatol 20:151–154PubMed Al-Fakhouri A, Manadan A, Gan J, Sreih AG (2014) Central diabetes insipidus as the presenting symptom of granulomatosis with polyangiitis. J Clin Rheumatol 20:151–154PubMed
25.
go back to reference Hughes J, Barkhoudarian G, Ciarlini P, Laws ER, Mody E, Inzucchi SE, Woodmansee WW (2013) Refractory pituitary granulomatosis with polyangiitis (Wegener’s) treated with rituximab. Endocr Pract 19:e1–e7CrossRefPubMed Hughes J, Barkhoudarian G, Ciarlini P, Laws ER, Mody E, Inzucchi SE, Woodmansee WW (2013) Refractory pituitary granulomatosis with polyangiitis (Wegener’s) treated with rituximab. Endocr Pract 19:e1–e7CrossRefPubMed
26.
go back to reference Pereira EA, Plaha P, Hofer M, Karavitaki N, Cudlip SA (2013) Hypophyseal Wegener’s granulomatosis presenting by visual field constriction without hypopituitarism. Clin Neurol Neurosurg 115:762–764CrossRefPubMed Pereira EA, Plaha P, Hofer M, Karavitaki N, Cudlip SA (2013) Hypophyseal Wegener’s granulomatosis presenting by visual field constriction without hypopituitarism. Clin Neurol Neurosurg 115:762–764CrossRefPubMed
28.
go back to reference Kara O, Demirel F, Acar BC, Cakar N (2013) Wegener granulomatosis as an uncommon cause of panhypopituitarism in childhood. J Pediatr Endocrinol Metab 26:959–962CrossRefPubMed Kara O, Demirel F, Acar BC, Cakar N (2013) Wegener granulomatosis as an uncommon cause of panhypopituitarism in childhood. J Pediatr Endocrinol Metab 26:959–962CrossRefPubMed
29.
go back to reference Santoro SG, Guida AH, Furioso AE, Glikman P, Rogozinski AS (2011) Panhypopituitarism due to Wegener’s granulomatosis. Arq Bras Endocrinol Metabol 55:481–485CrossRefPubMed Santoro SG, Guida AH, Furioso AE, Glikman P, Rogozinski AS (2011) Panhypopituitarism due to Wegener’s granulomatosis. Arq Bras Endocrinol Metabol 55:481–485CrossRefPubMed
30.
go back to reference Tenorio Jimenez C, Montalvo Valdivieso A, López Gallardo G, Mcgowan B (2011) Pituitary involvement in Wegener’s granulomatosis: unusual biochemical findings and severe malnutrition. BMJ Case Rep. doi:10.1136/bcr.02.2011.3850 PubMed Tenorio Jimenez C, Montalvo Valdivieso A, López Gallardo G, Mcgowan B (2011) Pituitary involvement in Wegener’s granulomatosis: unusual biochemical findings and severe malnutrition. BMJ Case Rep. doi:10.​1136/​bcr.​02.​2011.​3850 PubMed
31.
go back to reference Barlas NB, Hassan HH, Al Badr FB, Bilal A (2011) Structural and functional involvement of pituitary gland in Wegener’s granulomatosis. Clin Neuroradiol 21:31–33CrossRefPubMed Barlas NB, Hassan HH, Al Badr FB, Bilal A (2011) Structural and functional involvement of pituitary gland in Wegener’s granulomatosis. Clin Neuroradiol 21:31–33CrossRefPubMed
32.
go back to reference Xue J, Wang H, Wu H, Jin Q (2009) Wegener’s granulomatosis complicated by central diabetes insipidus and peripheral neutrophy with normal pituitary in a patient. Rheumatol Int 29:1213–1217CrossRefPubMed Xue J, Wang H, Wu H, Jin Q (2009) Wegener’s granulomatosis complicated by central diabetes insipidus and peripheral neutrophy with normal pituitary in a patient. Rheumatol Int 29:1213–1217CrossRefPubMed
34.
go back to reference Thiryayi W, Donaldson MH, Border D, Tyagi A (2007) An enhancing pituitary lesion in a young woman: a diagnostic dilemma. J Clin Neurosci 14:286–288CrossRefPubMed Thiryayi W, Donaldson MH, Border D, Tyagi A (2007) An enhancing pituitary lesion in a young woman: a diagnostic dilemma. J Clin Neurosci 14:286–288CrossRefPubMed
35.
go back to reference Spísek R, Kolouchová E, Jensovský J, Rusina R, Fendrych P, Plas J, Bartůnková J (2006) Combined CNS and pituitary involvement as a primary manifestation of Wegener granulomatosis. Clin Rheumatol 25:739–742CrossRefPubMed Spísek R, Kolouchová E, Jensovský J, Rusina R, Fendrych P, Plas J, Bartůnková J (2006) Combined CNS and pituitary involvement as a primary manifestation of Wegener granulomatosis. Clin Rheumatol 25:739–742CrossRefPubMed
36.
go back to reference Seror R, Mahr A, Ramanoelina J, Pagnoux C, Cohen P, Guillevin L (2006) Central nervous system involvement in Wegener granulomatosis. Medicine (Baltimore) 85:54–65CrossRef Seror R, Mahr A, Ramanoelina J, Pagnoux C, Cohen P, Guillevin L (2006) Central nervous system involvement in Wegener granulomatosis. Medicine (Baltimore) 85:54–65CrossRef
37.
go back to reference Dutta P, Hayatbhat M, Bhansali A, Bambery P, Kakar N (2006) Wegener’s granulomatosis presenting as diabetes insipidus. Exp Clin Endocrinol Diabetes 114:533–536CrossRefPubMed Dutta P, Hayatbhat M, Bhansali A, Bambery P, Kakar N (2006) Wegener’s granulomatosis presenting as diabetes insipidus. Exp Clin Endocrinol Diabetes 114:533–536CrossRefPubMed
38.
go back to reference Düzgün N, Morris Y, Güllü S, Gürsoy A, Ensari A, Kumbasar OO, Duman M (2005) Diabetes insipidus presentation before renal and pulmonary features in a patient with Wegener’s granulomatosis. Rheumatol Int 26:80–82CrossRefPubMed Düzgün N, Morris Y, Güllü S, Gürsoy A, Ensari A, Kumbasar OO, Duman M (2005) Diabetes insipidus presentation before renal and pulmonary features in a patient with Wegener’s granulomatosis. Rheumatol Int 26:80–82CrossRefPubMed
39.
go back to reference Tao J, Dong Y (2003) Pituitary involvement in Wegener’s granulomatosis: a case report and review of the literature. Chin Med J (Engl) 116:1785–1788 Tao J, Dong Y (2003) Pituitary involvement in Wegener’s granulomatosis: a case report and review of the literature. Chin Med J (Engl) 116:1785–1788
40.
go back to reference Garovic VD, Clarke BL, Chilson TS, Specks U (2001) Diabetes insipidus and anterior pituitary insufficiency as presenting features of Wegener’s granulomatosis. Am J Kidney Dis 37:E5CrossRefPubMed Garovic VD, Clarke BL, Chilson TS, Specks U (2001) Diabetes insipidus and anterior pituitary insufficiency as presenting features of Wegener’s granulomatosis. Am J Kidney Dis 37:E5CrossRefPubMed
41.
go back to reference Tappouni R, Burns A (2000) Pituitary involvement in Wegener’s granulomatosis. Nephrol Dial Transplant 15:2057–2058CrossRefPubMed Tappouni R, Burns A (2000) Pituitary involvement in Wegener’s granulomatosis. Nephrol Dial Transplant 15:2057–2058CrossRefPubMed
42.
go back to reference Hajj-Ali RA, Uthman IW, Salti IA, Zaatari GS, Haddad MC, Nasr FW (1999) Wegener’s granulomatosis and diabetes insipidus. Rheumatology (Oxford) 38:684–685CrossRef Hajj-Ali RA, Uthman IW, Salti IA, Zaatari GS, Haddad MC, Nasr FW (1999) Wegener’s granulomatosis and diabetes insipidus. Rheumatology (Oxford) 38:684–685CrossRef
43.
go back to reference Katzman GL, Langford CA, Sneller MC, Koby M, Patronas NJ (1999) Pituitary involvement by Wegener’s granulomatosis: a report of two cases. AJNR Am J Neuroradiol 20:519–523PubMed Katzman GL, Langford CA, Sneller MC, Koby M, Patronas NJ (1999) Pituitary involvement by Wegener’s granulomatosis: a report of two cases. AJNR Am J Neuroradiol 20:519–523PubMed
44.
go back to reference Miesen WM, Janssens EN, van Bommel EF (1999) Diabetes insipidus as the presenting symptom of Wegener’s granulomatosis. Nephrol Dial Transplant 14:426–429CrossRefPubMed Miesen WM, Janssens EN, van Bommel EF (1999) Diabetes insipidus as the presenting symptom of Wegener’s granulomatosis. Nephrol Dial Transplant 14:426–429CrossRefPubMed
45.
go back to reference Bertken RD, Cooper VR (1997) Wegener granulomatosis causing sellar mass, hydrocephalus, and global pituitary failure. West J Med 167:44–47PubMedCentralPubMed Bertken RD, Cooper VR (1997) Wegener granulomatosis causing sellar mass, hydrocephalus, and global pituitary failure. West J Med 167:44–47PubMedCentralPubMed
46.
go back to reference Czarnecki EJ, Spickler EM (1995) MR demonstration of Wegener granulomatosis of the infundibulum, a cause of diabetes insipidus. AJNR Am J Neuroradiol 16:968–970PubMed Czarnecki EJ, Spickler EM (1995) MR demonstration of Wegener granulomatosis of the infundibulum, a cause of diabetes insipidus. AJNR Am J Neuroradiol 16:968–970PubMed
47.
go back to reference Roberts GA, Eren E, Sinclair H, Pelling M, Burns A, Bradford R, Maurice-Williams R, Black CM, Finer N, Bouloux PM (1995) Two cases of Wegener’s granulomatosis involving the pituitary. Clin Endocrinol (Oxf) 42:323–328CrossRef Roberts GA, Eren E, Sinclair H, Pelling M, Burns A, Bradford R, Maurice-Williams R, Black CM, Finer N, Bouloux PM (1995) Two cases of Wegener’s granulomatosis involving the pituitary. Clin Endocrinol (Oxf) 42:323–328CrossRef
48.
go back to reference Lohr KM, Ryan LM, Toohill RJ, Anderson T (1988) Anterior pituitary involvement in Wegener’s granulomatosis. J Rheumatol 15:855–857PubMed Lohr KM, Ryan LM, Toohill RJ, Anderson T (1988) Anterior pituitary involvement in Wegener’s granulomatosis. J Rheumatol 15:855–857PubMed
50.
go back to reference Haynes BF, Fauci AS (1978) Diabetes insipidus associated with Wegener’s granulomatosis successfully treated with cyclophosphamide. N Engl J Med 299:764CrossRefPubMed Haynes BF, Fauci AS (1978) Diabetes insipidus associated with Wegener’s granulomatosis successfully treated with cyclophosphamide. N Engl J Med 299:764CrossRefPubMed
52.
go back to reference Leslie KO, Gruden JF, Parish JM, Scholand MB (2007) Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease. Arch Pathol Lab Med 131:407–423PubMed Leslie KO, Gruden JF, Parish JM, Scholand MB (2007) Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease. Arch Pathol Lab Med 131:407–423PubMed
53.
go back to reference Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H (2012) Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22:21–30CrossRefPubMed Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H (2012) Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22:21–30CrossRefPubMed
54.
go back to reference Wallace ZS, Carruthers MN, Khosroshahi A, Carruthers R, Shinagare S, Stemmer-Rachamimov A, Deshpande V, Stone JH (2013) IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore) 92:206–216CrossRef Wallace ZS, Carruthers MN, Khosroshahi A, Carruthers R, Shinagare S, Stemmer-Rachamimov A, Deshpande V, Stone JH (2013) IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore) 92:206–216CrossRef
55.
go back to reference Schönermarck U, Lamprecht P, Csernok E, Gross WL (2001) Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology (Oxford) 40:178–184CrossRef Schönermarck U, Lamprecht P, Csernok E, Gross WL (2001) Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology (Oxford) 40:178–184CrossRef
56.
go back to reference Schur PH (1987) IgG subclasses—a review. Ann Allergy 58(89–96):99 Schur PH (1987) IgG subclasses—a review. Ann Allergy 58(89–96):99
57.
go back to reference Brouwer E, Tervaert JW, Horst G, Huitema MG, van der Giessen M, Limburg PC, Kallenberg CG (1991) Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener’s granulomatosis and clinically related disorders. Clin Exp Immunol 83:379–386PubMedCentralCrossRefPubMed Brouwer E, Tervaert JW, Horst G, Huitema MG, van der Giessen M, Limburg PC, Kallenberg CG (1991) Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener’s granulomatosis and clinically related disorders. Clin Exp Immunol 83:379–386PubMedCentralCrossRefPubMed
58.
go back to reference Holland M, Hewins P, Goodall M, Adu D, Jefferis R, Savage CO (2004) Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener’s granulomatosis: a possible pathogenic role for the IgG4 subclass. Clin Exp Immunol 138:183–192PubMedCentralCrossRefPubMed Holland M, Hewins P, Goodall M, Adu D, Jefferis R, Savage CO (2004) Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener’s granulomatosis: a possible pathogenic role for the IgG4 subclass. Clin Exp Immunol 138:183–192PubMedCentralCrossRefPubMed
59.
go back to reference Liu LJ, Chen M, Yu F, Zhao MH, Wang HY (2008) IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener’s granulomatosis and microscopic polyangiitis. Nephrology (Carlton) 13:629–635CrossRef Liu LJ, Chen M, Yu F, Zhao MH, Wang HY (2008) IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener’s granulomatosis and microscopic polyangiitis. Nephrology (Carlton) 13:629–635CrossRef
Metadata
Title
A diagnostic pitfall in IgG4-related hypophysitis: infiltration of IgG4-positive cells in the pituitary of granulomatosis with polyangiitis
Authors
Hironori Bando
Genzo Iguchi
Hidenori Fukuoka
Masaaki Taniguchi
Seiji Kawano
Miki Saitoh
Kenichi Yoshida
Ryusaku Matsumoto
Kentaro Suda
Hitoshi Nishizawa
Michiko Takahashi
Akio Morinobu
Eiji Kohmura
Wataru Ogawa
Yutaka Takahashi
Publication date
01-10-2015
Publisher
Springer US
Published in
Pituitary / Issue 5/2015
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-015-0650-9

Other articles of this Issue 5/2015

Pituitary 5/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.